FDA launches Lupus Treatment Consortium in partnership with the Lupus Research Alliance
FDA ’s Center for Drug Evaluation and Research has partnered with the Lupus Research Alliance (LRA) to launch the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), a first-of-its-kind public-private partnership focused on addressing challenges impacting lupus clinical trial success. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 29, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Anifrolumab Shows Promise in Refractory Discoid Lupus Anifrolumab Shows Promise in Refractory Discoid Lupus
The study evaluated the records of eight women with DLE recalcitrant to standard therapies who were treated with anifrolumab for at least 8 weeks.MDedge News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - March 27, 2023 Category: Rheumatology Tags: Dermatology News Source Type: news
Beatriz v. El Salvador Case Could Set Precedent on Abortion in Latin America
On Mar. 22, 2023, dozens of people watched a live broadcast from San José, Costa Rica, on a large screen at the University of El Salvador, in San Salvador, of the open hearing of the Inter-American Court of Human Rights, listening to the testimony of witnesses in the Beatriz v. El Salvador case. The screenshot shows Beatriz's mother giving her testimony. CREDIT: Edgardo Ayala/IPSBy Edgardo AyalaSAN SALVADOR , Mar 24 2023 (IPS) An open hearing in the Inter-American Court of Human Rights in the Beatriz v. El Salvador case is raising hopes that this country and other Latin American nations might overturn or at least mitigate...
Source: IPS Inter Press Service - Health - March 24, 2023 Category: International Medicine & Public Health Authors: Edgardo Ayala Tags: Active Citizens Civil Society Crime & Justice Development & Aid Editors' Choice Featured Gender Headlines Health Human Rights Latin America & the Caribbean Regional Categories Women's Health Abortion El Salvador Inter-America Source Type: news
New Lupus Drug Cuts Skin Disease When Other Agents Fail
(MedPage Today) -- Every patient with discoid lupus erythematosus (DLE) that had not responded to multiple standard medications showed substantial improvement when put on anifrolumab (Saphnelo) in a small retrospective study, researchers said... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 16, 2023 Category: Dermatology Source Type: news
IL-1 Blocker Cuts Lupus Skin Disease When Other Drugs Fail
(MedPage Today) -- Every patient with discoid lupus erythematosus (DLE) that had not responded to multiple standard medications showed substantial improvement when put on anifrolumab (Saphnelo) in a small retrospective study, researchers said... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 15, 2023 Category: Dermatology Source Type: news
Selena Gomez Reflects on Body-Shaming After Lupus Diagnosis: ‘Nobody Deserves to Hear Those Things’
Selena Gomez sat down for the newest episode of the Apple TV+ series Dear… on Friday (March 10) to discuss her experience with lupus and body-shaming trolls. The superstar explained that after she was first diagnosed with the disease, she “didn’t quite understand what that meant” at the time. “I…#selenagomez #apple #sweetthrowbackphoto #franciarasia #haileybieber #tiktok (Source: Reuters: Health)
Source: Reuters: Health - March 10, 2023 Category: Consumer Health News Source Type: news
Experts Share Experience Prescribing Voclosporin, Belimumab Experts Share Experience Prescribing Voclosporin, Belimumab
While some rheumatologists expressed a treatment preference, patients with lupus nephritis tend to do well with both medications; cost and awareness are issues that hold back prescribing in some areas.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - March 9, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news
I Feel Like I ’m Burning Alive. It ’ s Hard for People to Believe Me
In 2018, I woke up on my birthday around 2 or 3 a.m. with a funny feeling in my left hand. It started as a slight itch on my thumb that quickly morphed into a different sensation—the feeling of the thumb beginning to swell, followed by the same feeling in my fingers and sections of my palm, until my hand was almost double its normal size. Later that morning, I visited an orthopedist I’d seen once or twice before for other reasons. He gave me a shot to prevent further swelling, and I went on my way. It was an unremarkable visit. Soon after, another strange thing happened: My hands began to feel like they were on...
Source: TIME: Health - February 24, 2023 Category: Consumer Health News Authors: Je Banach Tags: Uncategorized Evergreen freelance health Source Type: news
Lupus, RA Tied to Higher Risk for Adverse Obstetric, Birth Outcomes
THURSDAY, Feb. 23, 2023 -- Women with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) and their infants experience higher rates of adverse obstetric and birth outcomes, according to a study published online Jan. 10 in Arthritis Care... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 23, 2023 Category: Pharmaceuticals Source Type: news
Selena Gomez Gets Candid About Gaining Weight Due to Lupus Medication
Selena Gomez is happy with her body and anyone who doesn't like it can just “go away.” During a TikTok Live on Thursday, the pop star addressed recent criticism of her physique, revealing that her fluctuating weight is the result of her lupus medication. “When I’m taking it, I tend to hold a lot…#selenagomez #duringatiktoklive #twitter #onlymurders #vanityfair #tiktok (Source: Reuters: Health)
Source: Reuters: Health - February 17, 2023 Category: Consumer Health News Source Type: news
New Tool Better Estimates CV Risk in People With Lupus New Tool Better Estimates CV Risk in People With Lupus
A tool to estimate cardiovascular risk in systemic lupus erythematosus incorporates disease-specific variables.MDedge News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - February 16, 2023 Category: Rheumatology Tags: Rheumatology News Source Type: news
Two Biomarkers Identify High-Risk Lupus Nephritis Two Biomarkers Identify High-Risk Lupus Nephritis
Two biomarkers, elastase-DNA and HMGB1-DNA, correlate with poor outcomes in patients with lupus nephritis.MDedge News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 14, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Older Lupus Patients Need Follow-Up After Hospital Discharge ... or Else
(MedPage Today) -- Medicare beneficiaries 65 and older with lupus faced dramatically higher mortality when they received no follow-up care during the month after a hospital stay, researchers found.
Death rates within 30 days of discharge were... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 9, 2023 Category: Primary Care Source Type: news
Janssen Reports Positive Topline Phase 2 Results for Nipocalimab in Pregnant Individuals at High Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
SPRING HOUSE, PENNSYLVANIA, February 6, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced positive topline results from the proof-of-concept Phase 2 open-label UNITY clinical trial for the treatment of pregnant adults at high risk for severe hemolytic disease of the fetus and newborn (HDFN). HDFN is a serious and rare condition which can cause life-threatening anemia in the fetus. It occurs when the blood types of a pregnant individual and their fetus are incompatible.1 The trial met the primary endpoint, with the majority of pregnant patients who received nipocalimab achieving a live b...
Source: Johnson and Johnson - February 8, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Autoimmune diseases and women ’s health spotlighted during webinar
<img width="100" src="https://factor.niehs.nih.gov/sites/niehs-factor/files/styles/large/public/2022/2/community-impact/autoimmune-diseases/thumb931016.jpg?itok=XxAzkdWt" /><br /><p>Members of the NIEHS Women's Health Awareness community learned how conditions such as lupus can affect pregnancy, during Jan. 13 event.</p>
(read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - February 3, 2023 Category: Environmental Health Source Type: news
